Cargando…
EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747459/ http://dx.doi.org/10.1016/j.jval.2022.09.332 |
| _version_ | 1784849603862986752 |
|---|---|
| author | Maschio, M Schweikert, B Ultsch, B Cai, R Fust, K Lee, A Nasir, A Buck, P Van de Velde, N Kohli, M |
| author_facet | Maschio, M Schweikert, B Ultsch, B Cai, R Fust, K Lee, A Nasir, A Buck, P Van de Velde, N Kohli, M |
| author_sort | Maschio, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9747459 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97474592022-12-14 EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance Maschio, M Schweikert, B Ultsch, B Cai, R Fust, K Lee, A Nasir, A Buck, P Van de Velde, N Kohli, M Value Health Article Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747459/ http://dx.doi.org/10.1016/j.jval.2022.09.332 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Maschio, M Schweikert, B Ultsch, B Cai, R Fust, K Lee, A Nasir, A Buck, P Van de Velde, N Kohli, M EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title | EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title_full | EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title_fullStr | EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title_full_unstemmed | EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title_short | EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance |
| title_sort | ee80 the potential clinical and economic benefits of a next generation omicron-containing (ba.1) bivalent sars-cov-2 booster compared to first generation prototype boosters in germany assuming ba.4/ba.5 dominance |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747459/ http://dx.doi.org/10.1016/j.jval.2022.09.332 |
| work_keys_str_mv | AT maschiom ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT schweikertb ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT ultschb ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT cair ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT fustk ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT leea ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT nasira ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT buckp ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT vandevelden ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance AT kohlim ee80thepotentialclinicalandeconomicbenefitsofanextgenerationomicroncontainingba1bivalentsarscov2boostercomparedtofirstgenerationprototypeboostersingermanyassumingba4ba5dominance |